Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Producing and concentrating lenti-Cre for mouse infections.

Gierut JJ, Jacks TE, Haigis KM.

Cold Spring Harb Protoc. 2014 Mar 1;2014(3):304-6. doi: 10.1101/pdb.prot073437.

2.

Production and purification of lentiviral vectors.

Tiscornia G, Singer O, Verma IM.

Nat Protoc. 2006;1(1):241-5.

PMID:
17406239
3.

In vivo delivery of lenti-Cre or adeno-Cre into mice using intranasal instillation.

Gierut JJ, Jacks TE, Haigis KM.

Cold Spring Harb Protoc. 2014 Mar 1;2014(3):307-9. doi: 10.1101/pdb.prot073445.

4.

Efficient delivery of Cre-recombinase to neurons in vivo and stable transduction of neurons using adeno-associated and lentiviral vectors.

Ahmed BY, Chakravarthy S, Eggers R, Hermens WT, Zhang JY, Niclou SP, Levelt C, Sablitzky F, Anderson PN, Lieberman AR, Verhaagen J.

BMC Neurosci. 2004 Jan 30;5:4.

5.

Lentiviral vector-mediated gene transfer in embryonic stem cells.

Oka M, Chang LJ, Costantini F, Terada N.

Methods Mol Biol. 2006;329:273-81.

PMID:
16845997
6.

Placenta-specific gene activation and inactivation using integrase-defective lentiviral vectors with the Cre/LoxP system.

Morioka Y, Isotani A, Oshima RG, Okabe M, Ikawa M.

Genesis. 2009 Dec;47(12):793-8. doi: 10.1002/dvg.20563.

PMID:
19830817
7.

Integrase defective, nonintegrating lentiviral vectors.

Michelini Z, Negri D, Cara A.

Methods Mol Biol. 2010;614:101-10. doi: 10.1007/978-1-60761-533-0_6.

PMID:
20225038
8.

Targeted gene modification in mouse ES cells using integrase-defective lentiviral vectors.

Okada Y, Ueshin Y, Hasuwa H, Takumi K, Okabe M, Ikawa M.

Genesis. 2009 Apr;47(4):217-23. doi: 10.1002/dvg.20469.

PMID:
19208434
9.

Delivery of the Cre recombinase by a self-deleting lentiviral vector: efficient gene targeting in vivo.

Pfeifer A, Brandon EP, Kootstra N, Gage FH, Verma IM.

Proc Natl Acad Sci U S A. 2001 Sep 25;98(20):11450-5.

10.

Integrase-defective lentiviral vectors: progress and applications.

Banasik MB, McCray PB Jr.

Gene Ther. 2010 Feb;17(2):150-7. doi: 10.1038/gt.2009.135. Review.

PMID:
19847206
11.

HIV-1-based lentiviral vectors.

Liu YP, Berkhout B.

Methods Mol Biol. 2014;1087:273-84. doi: 10.1007/978-1-62703-670-2_22.

PMID:
24158830
12.

In vivo manipulation of gene expression in non-human primates using lentiviral vectors as delivery vehicles.

Dissen GA, Lomniczi A, Neff TL, Hobbs TR, Kohama SG, Kroenke CD, Galimi F, Ojeda SR.

Methods. 2009 Sep;49(1):70-7. doi: 10.1016/j.ymeth.2009.06.004. Review.

13.

Self-inactivating lentiviral vectors and a sensitive Cre-loxP reporter system.

Chang LJ, Zaiss AK.

Methods Mol Med. 2003;76:367-82. No abstract available.

PMID:
12526175
14.

Conditional mouse lung cancer models using adenoviral or lentiviral delivery of Cre recombinase.

DuPage M, Dooley AL, Jacks T.

Nat Protoc. 2009;4(7):1064-72. doi: 10.1038/nprot.2009.95.

15.

Double transduction of a Cre/LoxP lentiviral vector: a simple method to generate kidney cell-specific knockdown mice.

Nam BY, Kim DK, Park JT, Kang HY, Paeng J, Kim S, Park J, Um JE, Oh HJ, Han SH, Yoo TH, Kang SW.

Am J Physiol Renal Physiol. 2015 Dec 15;309(12):F1060-9. doi: 10.1152/ajprenal.00251.2015.

PMID:
26377795
16.

Trophoblast-specific gene manipulation using lentivirus-based vectors.

Georgiades P, Cox B, Gertsenstein M, Chawengsaksophak K, Rossant J.

Biotechniques. 2007 Mar;42(3):317-8, 320, 322-5.

17.

Lentiviral vectors with a defective integrase allow efficient and sustained transgene expression in vitro and in vivo.

Philippe S, Sarkis C, Barkats M, Mammeri H, Ladroue C, Petit C, Mallet J, Serguera C.

Proc Natl Acad Sci U S A. 2006 Nov 21;103(47):17684-9.

18.

The effects of lentiviral gene therapy with bone morphogenetic protein-2-producing bone marrow cells on spinal fusion in rats.

Miyazaki M, Sugiyama O, Tow B, Zou J, Morishita Y, Wei F, Napoli A, Sintuu C, Lieberman JR, Wang JC.

J Spinal Disord Tech. 2008 Jul;21(5):372-9. doi: 10.1097/BSD.0b013e31814cf51d.

PMID:
18600149
19.

Stable gene transfer to muscle using non-integrating lentiviral vectors.

Apolonia L, Waddington SN, Fernandes C, Ward NJ, Bouma G, Blundell MP, Thrasher AJ, Collins MK, Philpott NJ.

Mol Ther. 2007 Nov;15(11):1947-54.

PMID:
17700544
20.

Cre-lox-regulated conditional RNA interference from transgenes.

Ventura A, Meissner A, Dillon CP, McManus M, Sharp PA, Van Parijs L, Jaenisch R, Jacks T.

Proc Natl Acad Sci U S A. 2004 Jul 13;101(28):10380-5.

Items per page

Supplemental Content

Support Center